tirzepatide stamford Retatrutide vs. Tirzepatide: Is the New "Triple G" Drug Better? Tirzepatide – Yaletown Peptides (PC)

Many patients inadvertently undermine their medication by continuing high-calorie foods, consuming liquid calories, or eating too quicklytirzepatide works best when paired with mindful eating of protein-rich, fiber-dense whole foods

Key Takeaways Tirzepatide vs semaglutide comes down to dual agonist vs single agonist: tirzepatide targets both GLP-1 and GIP receptors, while semaglutide targets GLP-1 alone The only head-to-head trial (SURPASS-2) found tirzepatide superior to semaglutide for both blood sugar control and weight loss In separate obesity trials, tirzepatide 15mg achieved 20.9% weight loss at 72 weeks vs semaglutide 2.4mg's 14.9% at 68 weeks Semaglutide has proven cardiovascular benefit (SELECT trial: 20% MACE reduction)

Weeks 13-24 (10mg-15mg): therapeutic phase By this point you should be at or approaching your maintenance dose

The clinical application of tirzepatide as a treatment for T2D has the potential to provide new insights into the disease and help unravel the role of GIP in its development

CAS number: 2023788-19-2